LUMBAR ERECTOR SPINAE PLANE BLOCK AS AN ALTERNATIVE POSTOPERATIVE ANALGESIA METHOD AFTER ACETABULAR SURGERY
Abstract
Background and Aims. Postoperative pain management with opioid-sparing regional analgesia during open acetabular osteosynthesis is preferable, but evidence for the lumbar erector spinae plane (ESP) block in acetabular surgery remains limited. Aim: To evaluate the efficacy and safety of ultrasound-guided lumbar ESP block after acetabular surgery.
Methods. In this pilot study, patients (n=23) underwent open acetabular osteosynthesis via a lateral approach. Immediately after surgery an ultrasound-guided ESP block at L3–L4 was performed with 20 mL of 0.375% levobupivacaine + 4 mg of dexamethasone. All patients received ketoprofen 100 mg three times daily; intravenous opioids were used for rescue analgesia. Study endpoints were pain intensity on a numeric rating scale (NRS) at rest and during movement at 3, 6, and 24 h; time to return of pain sensation; opioid consumption in morphine equivalents during the first and second 24 h; and block-related complications.
Results. The mean age was 41±6 (95% CI 38.4–43.5) years; 19 (83%) patients were male. Mechanisms were road traffic accidents in 17 (74%) and falls from height in 6 (26%). NRS at rest and during movement was, respectively, 1.6±0.8 (95% CI 1.2–1.9) and 4.5±0.3 (95% CI 4.3–4.6) at 3 h; 2.2±0.6 (95% CI 1.9–2.4) and 4.4±0.4 (95% CI 4.2–4.5) at 6 h; and 1.3±0.5 (95% CI 1.08–1.5) and 4.9±0.6 (95% CI 4.6–5.1) at 24 h. The mean time to return of pain sensation was 9.3±1.6 h (95% CI 8.6–9.9). Opioid use was 15.3±6.2 mg (95%CI 12.6–17.9) in the first 24 h and 0.8±4.3 mg (95%CI 1.0–2.6) in the second 24 h. No block-related complications were observed.
Conclusions. A lumbar ESP block provided effective analgesia after acetabular osteosynthesis, reflected by a low NRS at rest, low opioid requirements, and no observed complications.
Metrics
Citations and online attention from Dimensions, Altmetric and PlumX.
License
Copyright (c) 2026 The Author(s)

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.